Analysts estimate that Zimmer Biomet Holdings will report an earnings per share (EPS) of $2.39.
Anticipation surrounds Zimmer Biomet Holdings's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
Last quarter the company beat EPS by $0.03, which was followed by a 1.1% increase in the share price the next day.
Here's a look at Zimmer Biomet Holdings's past performance and the resulting price change:
Quarter
Q3 2025
Q2 2025
Q1 2025
Q4 2024
EPS Estimate
1.87
1.98
1.77
2.29
EPS Actual
1.90
2.07
1.81
2.31
Price Change %
1.00
1.00
2.00
-2.00
Tracking Zimmer Biomet Holdings's Stock Performance
Shares of Zimmer Biomet Holdings were trading at $89.91 as of February 06. Over the last 52-week period, shares are down 10.51%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
Analyst Observations about Zimmer Biomet Holdings
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Zimmer Biomet Holdings.
Zimmer Biomet Holdings has received a total of 6 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $101.83, the consensus suggests a potential 13.26% upside.
Analyzing ...